Introduction
Bacillus subtilis, B. amyloliquefaciens, and B. licheniformis are often isolated from fermented soy foods, including Cheonggukjang, Doenjang, and Meju. The quality of fermented soy foods largely depends on types of bacilli and fungi grown on soybeans during fermentation because metabolites, such as peptides, amino acids, and other compounds, that are important for food quality are produced from soybeans by proteases and amylases secreted by bacilli and fungi (1) (2) (3) . Today, safety and functionality of foods are the most important consumer criteria for food selection (4) (5) . During fermentation, soy foods are exposed to a risk of contamination by pathogenic microorganisms, such as toxinogenic B. cereus and fungi, because fermentation is carried out in an open environment where pathogens often exist together with desirable organisms. For example, rice straw is used as a source of B. subtilis in traditional Cheonggukjang fermentation, but is also a source of B. cereus (6) (7) .
Often, soy foods prepared in traditional ways show poor qualities with unpleasant aromas and unattractive colors caused by organisms. Food poisoning can also occur if toxinogenic fungi or B. cereus are the contaminating organisms. Contamination with undesirable organisms also reduces food functionality because growth of desirable organisms is inhibited, resulting in reduced amounts of desirable metabolites in final products.
An effective method for enhancement of safety and functionality of fermented soy foods is use of Bacillus strains with desirable properties as starters. Desirable properties include an ability to inhibit growth of pathogenic microorganisms, an ability to produce bioactive compounds, and an ability to confer desirable organoleptic properties on fermented foods. Efforts have been made to isolate desirable Bacillus strains exhibiting antimicrobial activities from fermented soy foods (6) (7) (8) (9) , strains secreting fibrinolytic enzymes (10) (11) , and strains producing poly-γ-glutamic acid (12) (13) . However, only limited success has been reported regarding use of desirable strains as starters for improvement of safety and quality of fermented foods. Bacilli from fermented soy foods were isolated and strains were selected as starter candidates. B. amyloliquefaciens EMD17 exhibited a strong antimicrobial activity. In this study, properties of antimicrobial substances secreted by B. amyloliquefaciens EMD17 and potential use as a starter strain were investigated.
Materials and Methods
Isolation and identification of EMD17 from Cheonggukjang Cheonggukjang products prepared in traditional ways without starters were purchased at local markets at Jinju, Gyeongnam Province, Republic of Korea during the spring and summer of 2012. Ten g of Cheonggukjang was mixed with 90 mL of sterile water, homogenized using a Stomacher 80 (Seward, Worthing, UK), and serially diluted with sterile water. Diluted Cheonggukjang samples were spread on Luria-Bertani (LB) plates (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) and incubated for 48 h at 37 o C. Colonies exhibiting typical Bacillus morphologies were examined for antimicrobial activities using the agar spot method (14) . B. cereus ATCC14579 and an ochratoxin (OTA) producing Penicillium spp. were used as indicators. Bacilli were grown in LB for 48 h at 37 o C and 1 µL of a culture was spotted on an LB plate that was overlaid with LB top agar (0.7%, w/v) containing 50 µL of a B. cereus ATCC14579 culture grown in LB for 48 h. For antifungal activity testing, potato dextrose (PD) top agar (Becton, Dickinson and Company) containing 1x10 5 fungal spores was overlaid.
For identification of isolates, 16S rRNA and recA genes were amplified and nucleotide sequences were determined. Total DNA was prepared from a culture grown for 48 h in LB broth (8) . The 16S rRNA gene was amplified using the primer pair 27F (5'-AGAGTTT GATCMTGGCTCAG-3') and 1492R (5'-GGTTACCTTGTTACGACTT-3'). The recA gene was amplified using the primer pair recA-F (5'-TGAGTGATCGTCAGGCAGCCTTTAG-3') and recA-R (5'-CYTBRGATAAG ARTACCAWGMACCGC-3') (15). Sequencing was done at Cosmogenetech (Daejeon, Korea) and sequences were analyzed using the BLAST (Basic Local Alignment Search Tool) at NCBI (National Center for Biotechnology Information, Bethesda, MD, USA). Randomly amplified polymorphic DNA-PCR (RAPD-PCR) was done for total DNA using a 10-mer (S30; Bionics, Seoul, Korea) as described previously (15) .
Inhibition spectrum of B. amyloliquefaciens B. amyloliquefaciens EMD17 was grown in LB broth for 48 h at 37 o C with vigorous shaking and the culture was centrifuged at 8,000×g for 30 min at 4 o C. The supernatant was filtered using a 0.45 µm syringe filter (Minisart CE; Satorius Stedim, Aubagne, France) and the filtered supernatant (FS) was used for antimicrobial activity measurements following the agar well diffusion method (8) . An agar plate (1.5%, w/v) containing a medium specific for each indicator strain was overlaid with top agar (0.7%, w/v) containing 50 µL of an indicator culture that was grown to the early exponential phase (OD 600 =0.4). Indicators are listed in Table 1 . When fungi were used as indicators, potato dextrose agar (PDA) top agar (0.7%, w/v) containing 1x10
5 fungal spores was overlaid on an LB plate (16) . Holes were made in plates using a capillary glass tube and 100 µL of FS was placed into each hole. Plates were incubated for 48 h at 37 o C, and resulting inhibition zones around wells were measured.
B. amyloliquefaciens EMD17 production of antimicrobial substances The effect of the growth medium on the antimicrobial activity of B. amyloliquefaciens EMD17 was examined using the 4 different media LB, brain heart infusion (BHI) (Becton, Dickinson and Company), tryptic soy broth (TSB) (MB Cell, Los Angeles, CA, USA), and nutrient broth (NB) (Neogen, Lansing, MI, USA). Each medium (100 mL) was inoculated at 1% (v/v) with an overnight culture in LB and incubated up to 96 h with vigorous shaking at 37 o C. Aliquots were taken at time points and FS samples were obtained. FS antimicrobial activities were measured using the agar well diffusion method with B. cereus ATCC14579 as an indicator. Activity was expressed as an arbitrary unit (AU) per 1 mL and 1 AU was defined as the highest dilution showing a clear zone of inhibition (16) .
Stability of the antimicrobial substance against enzymes, pH, and heat treatment Effects of proteases, pH, and heat treatments on the antimicrobial activity of B. amyloliquefaciens EMD17 were examined using the agar well diffusion method with B. cereus ATCC14579 as the indicator. FS samples were prepared from a B. amyloliquefaciens EMD17 culture grown in NB for 48 h. Then FS from 48 h culture in NB was added with different amount (2, 5, 10%, v/v). In a separate experiment, a B. amyloliquefaciens EMD17 culture was added (1%, v/v) to a B. cereus culture. After addition of FS samples or cultures of B. amyloliquefaciens EMD17, B. cereus cultures were further incubated for 12 h and viable B. cereus cells were counted every 3 h. LB agar plates were used for B. cereus counting when FS was added, and Pemba plates (polymyxin pyruvate egg yolk mannitol bromothymol blue agar) (MB Cell) were used for cultures when a B. amyloliquefaciens EMD17 culture was added. Viable cell counting was repeated in triplicate and results were reported as a mean±standard deviation (SD).
PCR amplification of lipopeptide genes from B. amyloliquefaciens EMD17 Total DNA was prepared from B. amyloliquefaciens EMD17 cells grown overnight in LB as described previously (15) . Target lipopeptide genes and primers used are listed in C. Amplified products were extracted from an agarose gel (2%, w/v) using a gel extraction kit and nucleotide sequences were determined using the BLAST program at NCBI.
MS analysis of culture supernatants FS samples from 48 h cultures in NB were analyzed using an ultra-performance liquid chromatographyquadrupole-time-of-flight (UPLC-Q-TOF) mass spectrometer (MS) and NB broth was used as a control. A UPLC system (Waters, Milford, MA, USA) was used and analytical samples were injected into an Acquity UPLC BEH C 18 column (100 mm×2.1 mm×1.7 µm) (Waters) equilibrated with water containing 0.1% formic acid and eluted in a gradient with acetonitrile (ACN) containing 0.1% formic acid at a flow rate of 0.35/min for 13 min. Eluted metabolites were analyzed using Q-TOF MS (Waters) in electrospray ionization (ESI)-positive mode. The temperatures of the source and desolvation were set at 120 and 350 o C, respectively, and the desolvation flow rate was 600 L/h. Voltages of the capillary and sampling cones were set at 3 kV and 30 V, respectively. MS data were collected in the m/z=100-1,200 range with a scan time of 0.1 s. Lock spray with leucine-enkephalin (556.2771 Da) was used at a flow rate of 5 µL/min and a frequency of 10 s to ensure accuracy and reproducibility for all analyses. Detailed chemical compositional information about cyclic lipopeptides analyzed using UPLC-Q-TOF MS was provided from elemental composition analysis and was compared with chemical structures in the ChemSpider database.
Use of B. amyloliquefaciens EMD17 as a starter for Cheonggukjang and Doenjang Cheonggukjang was prepared from soybeans (2012 crop year, Hamyang, Gyeongnam, Republic of Korea). Soybeans (300 g) were soaked in water for 16 h at room temperature, then o C for up to 10 days. During the fermentation and storage period, soybean samples were taken for total bacilli and B. cereus counts using LB and Pemba plates, respectively. Doenjang was prepared using whole Meju soybeans (Kong-Al Meju) as described previously (18) 
Results and Discussion
Isolation and identification of B. amyloliquefaciens EMD17 Several bacilli that inhibited growth of B. cereus ATCC14579 were isolated from Cheonggukjang products. The EMD17 isolate that showed typical Bacillus morphology on LB agar plates was the most inhibitory strain. EMD17 also inhibited growth of an ochratoxin (OTA) producing Penicillium spp. strain. The 16S rRNA and recA genes were amplied from EMD17 genomic DNA using PCR and nucleotide sequences were determined. BLAST searches showed that the 1,197 bp 16S rRNA gene sequence was 100% identical with a 16S rRNA gene from B. amyloliquefaciens Y-32-1 (KT833128). The 710 bp recA sequence was 99% identical with B. amyloliquefaciens BEB33 (KJ009337). For species confirmation, RAPD-PCR was performed for genomic DNA from EMD17 using a 10-mer (S30) as a single primer, as described previously (15) . Two 1.1 and 1.5 kb fragments were amplified (results not shown) as unique bands of B. amyloliquefaciens strains (15). Thus, EMD17 was positively identified as a B. amyloliquefaciens. Genbank accession numbers were KJ000378 and KJ000380 for partial sequences of the 16S rRNA and recA genes, respectively. Effect of the growth medium on growth and antimicrobial activity of B. amyloliquefaciens EMD17 B. amyloliquefaciens EMD17 grew better in LB, BHI, and TSB media than in NB medium. Culture absorbance values (OD 600 ) increased quickly, reaching 1.2-1.4 at 6 h and more than 1.6 at 36 h in LB, BHI and TSB media. However, the value was 0.7 in NB at 6 h, and the highest value of 1.4 was reached at 48 h. In BHI and TSB broth, antimicrobial activities increased in a stepwise fashion and reached the highest activity of 160 AU/mL at 48 h in BHI and 60 h in TSB. In LB medium, the highest activity was 80 AU/mL at 48 h. In NB medium, the highest activity of 160 AU/mL was observed at 48 h. Antimicrobial activities decreased after reaching highest values in all media (results not shown). No activity was detected from cultures in BHI at 96 h. Although B. amyloliquefaciens EMD17 showed the same level of antimicrobial activity in all 3 media, NB was used as a subsequent medium for experimentation because the highest antimicrobial activity was reached earlier and some activity still remained at 96 h.
Stability of the antimicrobial substance against enzymes, pH, and heat treatment FS samples were treated with proteases and antimicrobial activities were not affected by proteinase K, protease, trypsin, and pepsin (results not shown). Unlike inhibitory substances in FS samples, BacW42, a bacteriocin secreted by B. subtilis W42 and used as a control herein, was completely destroyed by proteinase K (result not shown). Antimicrobial activities of FS samples were not affected after 30 min of exposure at 50, 60, 70, 80, 90, and 100 o C, even after 15 min at 121 o C. The antimicrobial activity was stable at pH 3 to 10 (results not shown). Thus, the antimicrobial substance in FS samples was not a bacteriocin. Considering the high stability and antifungal activity, the substance could be a cyclic lipopeptide, such as surfactin, fengycin, or iturin (21, 22) , compounds used in biotechnological and pharmaceutical processes due to surfaceinterface and antimicrobial properties (21) .
Inhibition mode of the antimicrobial substance The number of B. cereus ATCC14579 cells increased quickly in LB broth for the first 4 h, then increased gradually, reaching a maximum number of 4.4x10 8 CFU/mL at approximately 8 h. When a 1% B. amyloliquefaciens EMD17 culture was added to a B. cereus culture, B. cereus cells were killed rapidly and were not detected after 6 h when counted using Pemba B. cereus selective agar plates (Fig. 1) . Addition of 2, 5, 10% (v/v) FS samples reduced viable counts of B. cereus for the first 3 h, then after 3 h viable counts increased gradually for the next 12 h, after which viable counts were 3.8x10 PCR amplification of lipopeptide genes from B. amyloliquefaciens EMD17 The antimicrobial substance secreted by B. amyloliquefaciens EMD17 was not a bacteriocin, but was one of many different antimicrobials produced by bacilli. Lipopeptides are the major compounds responsible for antibacterial and antifungal activities. Surfactin, iturin, and fengycin are the most common lipopeptides with antifungal activities (21) . B. amyloliquefaciens strains secrete lipopeptides including surfactin, iturin, and fengycin into culture supernatants. When culture supernatants from B. amyloliquefaciens S13-3 were analyzed using ESI-MS/MS analysis, 11 lipopeptides were identified (20) . Surfactin, the most common lipopeptide and the most powerful biosurfactant, is a lipoheptapeptide interlinked with a hydroxyl fatty acid of length C12-C17 (22) . Surfactin shows antibacterial, antifungal, antiviral, and antitumoral activities and also inhibits fibrin clot formation. Considering antibacterial and antifungal activities, and high substance stability, surfactin was suspected to be the major agent, if not the sole agent, for the antimicrobial activity of B. amyloliquefaciens EMD17. The presence of a surfactin synthetase gene in the genome of B. amyloliquefaciens EMD17 was examined using PCR (Table 2) . A 210 bp fragment was amplified and sequenced ( Fig. 2A lane 1, and 2B ). The sequence was 99% homologous to the surfactin synthetase A gene srfAA from B. amyloliquefaciens IT-45, to B. amyloliquefaciens subsp. plantarum CAU B946, and to B. amyloliquefaciens SQR9 (results not shown). The fragment was an internal region of a large gene encoding surfactin synthetase A of 3,584 amino acids, and the region was part of the condensation domain (WP_015416786.1). In addition to genes encoding surfactin, genes encoding fengycin and iturin were also present. DNA fragments were amplified using PCR and apparent fragment sizes matched expected sizes ( Fig. 2A) . Fragment nucleotide sequences were also identical with sequences of genes encoding fengycin and iturin (results not shown). Thus, lipopeptides, including surfactin, fengycin, and iturin, were probably produced and were important for the antimicrobial activity of B. amyloliquefaciens EMD17. The srfA and srf/lch genes were also identified in B. subtilis H27, B. subtilis W42, and B. amyloliquefaciens MJ1-4 when the same primers were used (results not shown). However, the main antibacterial substances inhibiting B. cereus are bacteriocins for B. subtilis H27 and B. subtilis W42 because inhibitory activities were destroyed by protease treatment (8, 17) , which was not observed for B. amyloliquefaciens EMD17.
Mass spectra of culture supernatants B. amyloliquefaciens EMD17 was grown in NB for 48 h and the resulting supernatant was analyzed using MS. Many metabolites in the size range of 1,000-1,200 Da were detected (Fig. 3A) . Main peak sizes were 1,008.7065, 1,021.5590, 1,022.7050, 1,035.5807, and 1,036.7189 (Fig. 3B) . Sizes of peaks 4 and 5 ( Fig. 3B) were identical to reported values of surfactin E of 1,022.7 and surfactin of 1,036.7 (20) . Sizes of peaks 1 and 2 ( Fig. 3B) were similar to sizes of lichenysin A (1,021.7, 1,035.7) produced by Bacillus licheniformis (26) . Lichenysin A is a cyclic lipoheptapeptide that is structurally similar to surfactin. Surfactins, fengycins, and iturins have similar sizes although the exact size is variable depending upon the specific structure of each lipopeptide (20) . PCR and mass spectrometry results indicated that B. amyloliquefaciens EMD17 produced lipopeptides, including surfactin, as the main inhibitory substances. Lipopeptides are generally believed to serve as weapons for hosts against other competing organisms in the same environment, but not enough studies have been done to understand the exact role and benefit of each compound (22) . Each Bacillus strain is differentially equipped with antimicrobials and, thus, characterization of antimicrobial substances should be done for each strain. Further studies of antimicrobial compounds of B. amyloliquefaciens EMD17 are necessary to understand exact inhibitory mechanisms, which will facilitate use of B. amyloliquefaciens EMD17 and other bacilli producing antimicrobial compounds as starters for fermented foods.
Inhibition of B. cereus by B. amyloliquefaciens EMD17 during soyfood fermentation During Cheonggukjang fermentation in which B. amyloliquefaciens EMD17 and B. cereus were co-inoculated, B. cereus cells were not detected after 12 h of fermentation and after 10 days of storage at 4 o C (results not shown). Thus, B. cereus cells were killed rapidly by B. amyloliquefaciens EMD17. B. amyloliquefaciens EMD17 showed higher inhibition activities against B. cereus than against other bacilli. B. subtilis W42, a bacteriocin producer, was used as a starter for Cheonggukjang and inhibited spiked B. cereus ATCC 11778 cells at 1x10 5 cells/g of dry soybean weight during
Cheonggukjjang fermentation. However, inhibition was not complete and 1.43x10 3 cells still remained after 72 h (27) . A high B. amyloliquefaciens level of anti-B. cereus activity was also observed during Doenjang fermentation. Doenjang was prepared using whole Meju soybeans. After 2 weeks of fermentation at 25 o C, B. cereus cells were no longer detected (Fig. 4) . Total bacilli counts were stable during a 10-week fermentation period, and no B. cereus cells were detected on Pemba plates after 2 weeks. Thus, the strong inhibition activity of B. amyloliquefaciens EMD17 against B. cereus cells in soybean fermentation environments was confirmed. Since the number of intentionally spiked B. cereus cells was high at 10 4 cells/g of soybeans, B. amyloliquefaciens EMD17 probably prevented environmental B. cereus contamination of fermented soyfoods. Although many bacilli inhibit growth of B. cereus cells based on agar spot and well diffusion method results, real efficacies have not been confirmed in food systems. In this respect, B. amyloliquefaceines EMD17 is different from many other bacilli as the strain efficiently inhibited growth of B. cereus in Cheonggukjang and Doenjang fermentations. Potential use of B. amyloliquefaciens EMD17 as a starter for production of microbially safe fermented soyfoods is indicated. Detailed properties of Doenjang will be described in the future.
In addition to an antimicrobial activity, B. amyloliquefaciens EMD17 also exerted a fibrinolytic activity. Supernatants from 30 h cultures in TSB showed a highest fibrinolytic activity of 61.02 U among LB, BHI, TSB, and NB media (results not shown). Supernatants from 24 h cultures in LB showed the second highest activity of 46.83 U. B. amyloliquefaciens EMD17 exerts the 2 desirable properties of pathogenic microorganism inhibition and dissolution of fibrin and, thus, can be useful as a starter for fermented soy foods. The microbial safety of fermented soy foods can be improved by use of starters capable of inhibiting the growth of toxinogenic organisms, such as B. cereus and toxin producing fungi. Multiple starters consisting of 2-4 bacilli with different properties will be an effective method for increasing the microbial safety and the functionality of fermented soy foods. In this respect, B. amyloliquefaciens EMD17 can be used as a starter singly or in association with multiple starters. The real effectiveness of B. amyloliquefaciens as a starter needs to be further investigated. 
